Litcius/Paper detail

Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine

Sitthichai Kanokudom, Suvichada Assawakosri, Nungruthai Suntronwong, Jira Chansaenroj, Chompoonut Auphimai, Pornjarim Nilyanimit, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Ritthideach Yorsaeng, Thaneeya Duangchinda, Warangkana Chantima, Pattarakul Pakchotanon, Donchida Srimuan, Thaksaporn Thatsanatorn, Sirapa Klinfueng, Juthathip Mongkolsapaya, Natthinee Sudhinaraset, Nasamon Wanlapakorn, Sittisak Honsawek, Yong Poovorawan

2022Vaccine15 citationsDOIOpen Access PDF

Topics & Concepts

ReactogenicityImmunogenicityMedicineBooster (rocketry)Booster doseVirologyVaccinationImmunologyImmunizationAntibodyAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesImmunotherapy and Immune Responses
Comparison of the reactogenicity and immunogenicity of a reduced and standard booster dose of the mRNA COVID-19 vaccine in healthy adults after two doses of inactivated vaccine | Litcius